Investing.com -- Shares of Finnish pharmaceutical company Orion (HE: ORNAV) fell more than 7% on Tuesday after the company ...
4d
Orion Oyj (ORINY) Q3 2025 Earnings Call Highlights: Strong Financial Performance Amid Delivery ...
Orion Oyj (ORINY) reports robust growth in operating profit and innovative medicines, despite facing delivery delays and increased fixed costs.
OCTOBER 2025 at 12:00 EET Orion Group Interim Report January–September 2025 July–September 2025 Highlights Net sales totalled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback